Kassa Ayalew, MD, MPH
Director, Division of Clinical Compliance Evaluation
Office of Scientific Investigation, Center for Drug Evaluation and Research (CDER), U.S. Food & Drug Administration (FDA)
Dr. Kassa Ayalew is Division Director for the Division of Clinical Compliance Evaluation in the Office of Scientific Investigation at Center for Drug Evaluation and Research (CDER) in FDA. Dr. Ayalew oversees verification of the integrity of efficacy and safety data submitted to the FDA in support of new drug and biologic applications and the protection and assurance of the rights and welfare of human research subjects.
Dr. Ayalew holds an active license to practice medicine in the State of Virginia. He is board certified in Pediatrics and Infectious Disease. Dr. Ayalew also works in Urgent Care in Virginia where he provides clinical services to both pediatrics and adult patients. He has given numerous didactic lectures, case presentations and published publications in peer review journals. He has decades of clinical and regulatory work experience.